Literature DB >> 23281413

Molecular and genetic basis of sudden cardiac death.

Alfred L George1.   

Abstract

The abrupt cessation of effective cardiac function due to an aberrant heart rhythm can cause sudden and unexpected death at any age, a syndrome called sudden cardiac death (SCD). Annually, more than 300,000 cases of SCD occur in the United States alone, making this a major public health concern. Our current understanding of the mechanisms responsible for SCD has emerged from decades of basic science investigation into the normal electrophysiology of the heart, the molecular physiology of cardiac ion channels, fundamental cellular and tissue events associated with cardiac arrhythmias, and the molecular genetics of monogenic disorders of heart rhythm. This knowledge has helped shape the current diagnosis and treatment of inherited arrhythmia susceptibility syndromes associated with SCD and has provided a pathophysiological framework for understanding more complex conditions predisposing to this tragic event. This Review presents an overview of the molecular basis of SCD, with a focus on monogenic arrhythmia syndromes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281413      PMCID: PMC3533278          DOI: 10.1172/JCI62928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  130 in total

1.  Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.

Authors:  Matteo Vatta; Robert Dumaine; George Varghese; Todd A Richard; Wataru Shimizu; Naohiko Aihara; Koonlawee Nademanee; Ramon Brugada; Josep Brugada; Gumpanart Veerakul; Hua Li; Neil E Bowles; Pedro Brugada; Charles Antzelevitch; Jeffrey A Towbin
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

2.  Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.

Authors:  Ghayath Baroudi; Said Acharfi; Chantal Larouche; Mohamed Chahine
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

3.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

4.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

5.  Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.

Authors:  G Alex Papadatos; Polly M R Wallerstein; Catherine E G Head; Rosemary Ratcliff; Peter A Brady; Klaus Benndorf; Richard C Saumarez; Ann E O Trezise; Christopher L-H Huang; Jamie I Vandenberg; William H Colledge; Andrew A Grace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.

Authors:  Dagmar I Keller; Hai Huang; Juan Zhao; Rudolf Frank; Vivian Suarez; Etienne Delacrétaz; Marijke Brink; Stefan Osswald; Nicola Schwick; Mohamed Chahine
Journal:  Cardiovasc Res       Date:  2006-03-03       Impact factor: 10.787

7.  Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).

Authors:  Martin Tristani-Firouzi; Judy L Jensen; Matthew R Donaldson; Valeria Sansone; Giovanni Meola; Angelika Hahn; Said Bendahhou; Hubert Kwiecinski; Anna Fidzianska; Nikki Plaster; Ying-Hui Fu; Louis J Ptacek; Rabi Tawil
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.

Authors:  Gregor Andelfinger; Andrew R Tapper; Richard C Welch; Carlos G Vanoye; Alfred L George; D Woodrow Benson
Journal:  Am J Hum Genet       Date:  2002-07-29       Impact factor: 11.025

9.  Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block.

Authors:  Sridharan Rajamani; Corey L Anderson; Blake D Anson; Craig T January
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

10.  Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors:  Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more
  33 in total

1.  High-Throughput Functional Evaluation of KCNQ1 Decrypts Variants of Unknown Significance.

Authors:  Carlos G Vanoye; Reshma R Desai; Katarina L Fabre; Shannon L Gallagher; Franck Potet; Jean-Marc DeKeyser; Daniela Macaya; Jens Meiler; Charles R Sanders; Alfred L George
Journal:  Circ Genom Precis Med       Date:  2018-11

2.  Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.

Authors:  Zhaoyang Hu; Ritu Kant; Marie Anand; Elizabeth C King; Trine Krogh-Madsen; David J Christini; Geoffrey W Abbott
Journal:  Circ Cardiovasc Genet       Date:  2014-01-08

3.  Cardiovascular science: opportunities for translating research into improved care.

Authors:  Eugene Braunwald
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

4.  Copy number variants and the genetic enigma of congenital heart disease.

Authors:  Ali J Marian
Journal:  Circ Res       Date:  2014-10-24       Impact factor: 17.367

5.  Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity.

Authors:  Sam Chai; Xiaoping Wan; Angelina Ramirez-Navarro; Paul J Tesar; Elizabeth S Kaufman; Eckhard Ficker; Alfred L George; Isabelle Deschênes
Journal:  J Clin Invest       Date:  2018-02-12       Impact factor: 14.808

Review 6.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

7.  Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.

Authors:  Thomas M Beckermann; Karen McLeod; Victoria Murday; Franck Potet; Alfred L George
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

8.  Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction.

Authors:  Zhaoyang Hu; Shawn M Crump; Ping Zhang; Geoffrey W Abbott
Journal:  Cardiovasc Res       Date:  2016-03-06       Impact factor: 10.787

9.  Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.

Authors:  Malcolm Hoshi; Xi X Du; Krekwit Shinlapawittayatorn; Haiyan Liu; Sam Chai; Xiaoping Wan; Eckhard Ficker; Isabelle Deschênes
Journal:  Circ Cardiovasc Genet       Date:  2014-02-26

10.  Galactokinase is a novel modifier of calcineurin-induced cardiomyopathy in Drosophila.

Authors:  Teresa E Lee; Lin Yu; Matthew J Wolf; Howard A Rockman
Journal:  Genetics       Date:  2014-07-31       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.